Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04941807 · ClinicalTrials.gov registry record · Phase 4
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT04941807: Completed Phase 4 study, sponsored by Weill Medical College of Cornell University.
NCT04941807 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 11 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04941807, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome
Primary Outcome
The PGIA will be based on a comparison of photographs taken at baseline to the nails at week 16 of follow-up. The Physician Global Improvement Score (PGIA) evaluates the improvement of lamellar splitting, transverse splitting, ridges, longitudinal grooves, longitudinal splitting, and nail thickness in target fingernails. Change is classified as excellent, good, or fair, or categorized as no improvement or worsening.
Interventions
- DEVICE Platelet-rich plasma
- DEVICE Platelet-poor plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-03-04 |
| Est. Completion | 2023-04-12 |
| Phase | Phase 4 |
What the finished NCT04941807 record still lists
NCT04941807 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Platelet-rich plasma is the first listed.
NCT04941807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04941807 about?
NCT04941807 is a clinical study titled "Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome". The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome
What is the current status of trial NCT04941807?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2021-03-04. Estimated completion is 2023-04-12.
What interventions are being tested in trial NCT04941807?
The interventions under investigation include: Platelet-rich plasma (DEVICE), Platelet-poor plasma (DEVICE).
Who is sponsoring clinical trial NCT04941807?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04941807's enrollment target sits among peer trials
11 1931st of 2000 higher than 61 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI